教 授 　中川　貴之　(Takayuki NAKAGAWA)
（和歌山県立医科大学附属病院薬剤部?薬剤部長）

2022年

Itohara K, Yano I, Nakagawa S, Sugimoto M, Hirai M, Yonezawa A, Imai S, Nakagawa T, Hira D, Ito T, Hata K, Hatano E, Terada T, Matsubara K. Population pharmacokinetics of everolimus in adult liver transplant patients: Comparison to tacrolimus disposition and extrapolation to pediatrics. Clin Transl Sci 15(11): 2652-2662 (2022). doi: 10.1111/cts.13389.

Matsuda Y, Nakagawa S, Yano I, Masuda S, Imai S, Yonezawa A, Yamamoto T, Sugimoto M, Tsuda M, Tsuzuki T, Omura T, Nakagawa T, Chen-Yoshikawa TF, Nagao M, Date H, Matsubara K: Effect of itraconazole and its metabolite hydroxyitraconazole on the blood concentrations of cyclosporine and tacrolimus in lung transplant recipients. Biol Pharm Bull 45(4): 397-402 (2022). https://doi.org/10.1248/bpb.b21-00738.

Shigetsura Y, Imai S, Endo H, Shimizu Y, Ueda K, Murai T, Itohara K, Nakagawa S, Yonezawa A, Ikemi Y, Fukatsu S, Kitada N, Terada T, Nakagawa T, Matsubara K: Assessment of suvorexant and eszopiclone as alternatives to benzodiazepines for treating insomnia in patients with major depressive disorder. Clin Neuropharmaco 45(3): 52–60 (2022). doi: 10.1097/WNF.0000000000000499.

Uchida M, Suzuki S, Sugawara H, Suga Y, Nakagawa T, Takase H: Multicentre prospective observational study on community pharmacist interventions to reduce inappropriate medications. Int J Pharm Pract 30(5): 427-433 (2022). doi:10.1093/ijpp/riac032.

Masui S, Yonezawa A, Momo K, Nakagawa S, Itohara K, Imai S, Nakagawa T, Matsubara K: Infliximab treatment persistence among Japanese patients with chronic inflammatory diseases: a retrospective Japanese claims data study. Biol Pharm Bull 45: 323-332 (2022). doi: 10.1248/bpb.b21-00906.

Sukeishi A, Itohara K, Yonezawa A, Sato Y, Matsumura K, Katada Y, Nakagawa T, Hamada S, Tanabe N, Imoto E, Kai S, Hirai T, Yanagita M, Ohtsuru S, Terada T, Ito I. Population pharmacokinetic modeling of GS-441524, the active metabolite of remdesivir, in Japanese COVID-19 patients with renal dysfunction. CPT Pharmacometrics Syst Pharmacol 11: 94-103 (2022). doi: 10.1002/psp4.12736.

石村裕樹、片田佳希、梅山 遥、杉本充弘、北田徳昭、米澤 淳、中川貴之、新井康之、髙折晃史、寺田智祐. レテルモビルの中止によりボリコナゾールの血中濃度が著明に上昇した造血幹細胞移植後の1症例. 日本病院薬剤師会雑誌 58: 35-39 (2022)

2021年

Osada Y, Nakagawa S, Ishibe K, Takao S, Shimazaki A, Itohara K, Imai S, Yonezawa A, Nakagawa T, Matsubara K. Antibiotic-induced microbiome depletion alters renal glucose metabolism and exacerbates renal injury after ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 321: F455-F465 (2021)

Katada Y, Nakagawa S, Nagao M, Yoshida Y, Matsuda Y, Yamamoto Y, Itohara K, Imai S, Yonezawa A, Nakagawa T, Matsubara K, Tanaka S, Nakajima D, Date H, Terada T*. Risk factors of breakthrough aspergillosis in lung transplant recipients receiving itraconazole prophylaxis. J Infect Chemother 28: 54-60 (2022). doi: 10.1016/j.jiac.2021.09.020.

Itohara K, Yano I, Nakagawa S, Yonezawa A, Omura T, Imai S, Nakagawa T, Sawada A, Kobayashi T, Tochio A, Sakai K, Taura K, Ogawa O, Matsubara K. Extrapolation of physiologically based pharmacokinetic model for tacrolimus from renal to liver transplant patients. Drug Metab Pharmacokinet 42: 100423 (2021)

Nakae K, Masui S, Yonezawa A*, Hashimoto M, Watanabe R, Murata K, Murakami K, Tanaka M, Ito H, Yokoyama K, Iwamoto N, Shimada T, Nakamura M, Denda M, Itohara K, Nakagawa S, Ikemi Y, Imai S, Nakagawa T, Hayakari M, Matsubara K. Potential application of measuring serum infliximab levels in rheumatoid arthritis management: A retrospective study based on KURAMA cohort data. PLoS One 16: e0258601(2021). doi: 10.1371/journal.pone.0258601.

祝千佳子、今井哲司、高折彩、馬場長、万代昌紀、中川貴之*：難渋する神経障害性疼痛?しびれに対してデュロキセチンが著効した子宮体がん椎骨転移症例. 日本緩和医療薬学雑誌, 14: 111-114 (2021)

Nomura T, Sumi E, Egawa G, Nakajima S, Toichi E, Inoue N, Shibuya M, Okamoto N, Mitsuishi T, Uozumi R, Tada H, Nakagawa T, Kusuba N, Okuno A, Shimizuhira C, Ishikawa M, Tanaka S, Hagiwara M, Kabashima K : Safety and efficacy of the cyclin dependent kinase 9 (CDK9) inhibitor FIT039 for verruca vulgaris: a placebo-controlled, phase I/II randomized controlled trial. JID Innovations 1: 100026 (2021)

Tobori S, Hiyama H, Miyake T, Yano Y, Nagayasu K, Shirakawa H, Nakagawa T, Mori Y, Kaneko S: MrgprB4 in trigeminal neurons expressing TRPA1 modulates unpleasant sensations. J Pharmacol Sci 146: 200-205 (2021). doi: 10.1016/j.jphs.2021.04.006.

Jin C, Matsui Y, Yonezawa A*, Imai S, Ogihara T, Itohara K, Nakagawa S, Nakagawa T, Matsubara K: Complete deletion of Slc52a2 causes embryonic lethality in mice. Biol Pharm Bull 44: 283-286 (2021). doi: 10.1248/bpb.b20-00751.

Katada Y, Yonezawa A, Utsumi M, Kitada N, Sato Y, Matsumura K, Sukeishi A, Nakagawa S, Imai S, Nakagawa T, Minakata K, Kanemitsu H, Minatoya K, Nomoto S, Matsubara K*: Pharmacist-physician collaborative care for outpatients with left ventricular assist devices using a cloud-based home medical management information-sharing system: a case report. J Pharm Health Care Sci 7: 5 (2021). doi: 10.1186/s40780-020-00188-2.

Koyanagi M, Imai S*, Iwamitsu Y, Matsumoto M, Saigo M, Moriya A, Ogihara T, Nakazato Y, Yonezawa A, Nakagawa S, Nakagawa T, Matsubara K: Cilostazol is a promising causal therapy for preventing paclitaxel-induced peripheral neuropathy by suppression of Schwann cell dedifferentiation. Neuropharmacology 188: 108514 (2021). doi: 10.1016/j.neuropharm.2021.108514.

Koyanagi M, Imai S*, Matsumoto M, Iguma Y, Kawaguchi-Sakita N, Kotake T, Iwamitsu Y, Ntogwa M, Hiraiwa R, Nagayasu K, Saigo M, Ogihara T, Yonezawa A, Omura T, Nakagawa S, Nakagawa T, Matsubara K: Pro-nociceptive roles of Schwann cell-derived galectin-3 in taxane-induced peripheral neuropathy. Cancer Res 81: 2207-2219 (2021). doi: 10.1158/0008-5472.CAN-20-2799.

Ikuta K, Nakagawa S*, Momo K, Yonezawa A, Itohara K, Sato Y, Imai S, Nakagawa T, Matsubara K: Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case-control study. BMJ Open 11: e041543 (2021). doi: 10.1136/bmjopen-2020-041543.

Kamei J*, Aizawa N, Nakagawa T, Kaneko S, Fujimura T, Homma Y, Kume H, Igawa Y: Lacking transient receptor potential melastatin 2 attenuates lipopolysaccharide-induced bladder inflammation and its associated hypersensitivity in mice. Int J Urol 28: 107-114 (2021). doi: 10.1111/iju.14389.

2020年

片田佳希、中川俊作、山嶋仁実、杉本充弘、木全柾典、吉田優子、松田裕也、髙橋悠、糸原光太郎、北田徳昭、今井哲司、深津祥央、津田真弘、米澤淳、中川貴之、山本正樹、松村康史、長尾美紀、松原和夫: 体重に応じたテイコプラニン初期投与設計の 有効性と安全性に関する検討. 日本化学療法学会雑誌 68: 608-618 (2020)

Jin C, Yonezawa A*, Yoshimatsu H, Imai S, Koyanagi M, Yamanishi K, Nakagawa S, Itohara K, Omura T, Nakagawa T, Nagai J, Matsubara K: Effect of riboflavin deficiency on development of the cerebral cortex in Slc52a3 knockout mice. Sci Rep 10: 18443 (2020). doi: 10.1038/s41598-020-75601-9

Kondo M, Nakagawa S*, Orii S, Itohara K, Sugimoto M, Omura T, Sato Y, Imai S, Yonezawa A, Nakagawa T, Matsubara K: Association of initial trough concentrations of vancomycin with outcomes in pediatric patients with gram-positive bacterial infection. Biol Pharm Bull 43: 1463-1468 (2020). doi: 10.1248/bpb.b19-01003.

Ntogwa M, Imai S*, Hiraiwa R, Koyanagi M, Matsumoto M, Ogihara T, Nakagawa S, Omura T, Yonezawa A, Nakagawa T, Matsubara K: Schwann cell-derived CXCL1 contributes to human immunodeficiency virus type 1 gp120-induced neuropathic pain by modulating macrophage infiltration in mice. Brain Behav Immun 88: 325-339 (2020). doi: 10.1016/j.bbi.2020.03.027.

片田佳希、米澤 淳 、杉本充弘、木全柾典、吉田優子、糸原光太郎、中川俊作、北田徳昭、今井哲司、池見泰明、深津祥央、中川貴之、松村康史、長尾美紀、*松原和夫：抗インフルエンザ薬の適正使用指針（フォーミュラリ）導入のアウトカム評価. 日本病院薬剤師会雑誌 56: 1155-1260 (2020).

Yamashita K, Ogihara T, Hayashi M, Nakagawa T, Ishizaki Y, Kume M, Yano I, Niigata R, Hiraoka J, Yasui H, Nakamura T*: Association between dexamethasone treatment and alterations in serum concentrations of trace metals. Pharmazie 75: 218-222 (2020). doi: 10.1691/ph.2020.0341

Nagai Y, Takayama K, Nishitani N, Andoh C, Koda M, Shirakawa H, Nakagawa T, Nagayasu K*, Yamanaka A, Kaneko S*: The role of dorsal raphe serotonin neurons in the balance between reward and aversion. Int J Mol Sci 21: 2160 (2020). doi:10.3390/ijms21062160

Ohashi Ikeda H*, Muraoka Y, Hata M, Sumi E, Ikeda T, Nakagawa T, Abe H, Tada H, Morita S, Kakizuka S, Yoshimura N, Tsujikawa A: Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial. PLOS ONE 15: e0229068 (2020). doi: 10.1371/journal.pone.0229068.

Zhang Y, Yonezawa A*, Nakagawa A, Imai S, Denda M, Omura T, Nakagawa T, Matsubara K: Cisplatin, rather than oxaliplatin, increases paracellular permeability of LLC-PK1 cells via activating protein kinase C. Drug Metab Pharmacokinet 35: 111-116 (2020)

2019年

Ogihara T, *Nakagawa T, Hayashi M, Koyanagi M, Yonezawa A, Omura T, Nakagawa S, Kitada N, Imai S, Matsubara K: Improvement of peripheral vascular impairment by a phosphodiesterase type 5 inhibitor tadalafil prevents oxaliplatin-induced peripheral neuropathy in mice. J Pharmacol Sci 141: 131-138 (2019) doi: 10.1016/j.jphs.2019.10.005

NagaiY, Nishitani N, Yasuda M, Ueda Y, Fukui Y, Andoh C, Shirakawa H, Nakagawa T, Inoue K, *Nagayasu K, Kasparov S, Nakamura K, *Kaneko S: Identification of neuron-type specific promoters in monkey genome and their functional validation in mice. Biochem Biophys Res Commun 518: 619-624 (2019)

Nomura T*, Sumi E*, Egawa G, Nakajima S, Toichi E, Uozumi R, Tada H, Nakagawa T, Hagiwara M Kabashima K: The efficacy of a cyclin dependent kinase 9 (CDK9) inhibitor, FIT039, on verruca vulgaris: study protocol for a randomized controlled trial. Trails 20: 489 (2019) doi: 10.1186/s13063-019-3570-6.

Uchida M*, Suzuki S, Sugawara H, Suga Y, Kokubun H, Uesawa Y, Nakagawa T, Takase H: A nationwide survey of hospital pharmacist interventions to improve polypharmacy for patients with cancer in palliative care in Japan. J Pharm Health Care Sci 5: 14 (2019)

Suzuki S*, Uchida M, Suga Y, Sugawara H, Kokubun H, Uesawa Y, Nakagawa T, Takase H: A nationwide survey of community pharmacist contributions to polypharmacy in opioid-using and non-using cancer patients in Japan. Biol Pharm Bull 42: 1164-1171 (2019)

Sugawara H*, Uchida M, Suzuki S, Suga Y, Uesawa Y, Nakagawa T, Takase H: Analyses of respiratory depression associated with opioids in cancer patients based on the Japanese Adverse Drug Event Report Database. Biol Pharm Bull 42: 1185-1191 (2019)

Suga Y*, Uchida M, Suzuki S, Sugawara H, Torigoe K, Futamura A, Uesawa Y, Nakagawa T, Takase H: Current status of adverse events related with opioid analgesics in Japan: Assessment based on Japanese Adverse Drug Event Report database. Biol Pharm Bull 42: 801-806 (2019)

*Yonezawa A, Otani1 Y, Kitano T, Mori M, Masui S, Isomoto Y, Tsuda M, Imai S, Ikemi Y, Denda M, Sato Y, Nakagawa S, Omura T, Nakagawa T, Yano I, Hayakari M, Takaori-Kondo A, Matsubara K: Concentration and glycoform of rituximab in plasma of patients with B-cell non-Hodgkin's lymphoma. Pharm Res 36: 82 (2019)

Asaoka N, Nishitani N, Kinoshita H, Nagai Y, Hatakama H, Nagayasu K*, Shirakawa H, Nakagawa T, Kaneko S: An adenosine A_2A receptor antagonist improves multiple symptoms of repeated quinpirole induced psychosis. eNeuro 6: pii: eNEURO.0366-18.2019 (2019) DOI: 10.1523/ENEURO.0366-18.2019

Nishitani N, Nagayasu K*, Asaoka N, Yamashiro M, Andoh C, Nagai Y, Kinoshita H, Kawai H, Shibui N, Liu B, Hewinson J, Shirakawa H, Nakagawa T, Hashimoto H, Kasparov S, Kaneko S: Manipulation of dorsal raphe serotonergic neurons modulates active coping to inescapable stress and anxiety-related behaviors in mice and rats. Neuropsychopharmacology 44: 721-732 (2019) DOI: 10.1038/s41386-018-0254-y

Andoh A, Nishitani N, Hashimoto E, Nagai Y, Takao K, Miyakawa T, Nakagawa T, Mori Y, Nagayasu K, *Shirakawa H, Kaneko S: TRPM2 confers susceptibility to social stress but is essential for behavioral flexibility. Brain Res 1704: 68-77(2019) DOI:　10.1016/j.brainres.2018.09.031.

Katada Y, Nakagawa S, Nishimura A, Sato YK, Taue H, Matsumura K, Yamazaki K, Minakata K, Yano I, Omura T, Imai S, Yonezawa A, Sato Y, Nakagawa T, Minatoya K, Matsubara K: Effects of fasting on warfarin sensitivity index in patients undergoing cardiovascular surgery. Eur J Clin Pharmacol 75: 561-568 (2019)

2018年

*Nakagawa S, Nakaish M, HashimotoM, Ito H, Yamamoto W, Nakashima R, Tanaka M, Fujii T, Omura T, Imai S, Nakagawa T, Yonezawa A, Imai H, Mimori T, Matsubara K: Effect of medication adherence on disease activity among Japanese patients with rheumatoid arthritis. PLOS ONE 13: e0206943 (2018) doi: 10.1371/journal.pone.0206943.

*Omura T, Matsuda, H, Nomura L, Imai S, Denda M, Nakagawa S, Yonezawa A, Nakagawa T, Yano I, Matsubara K. Ubiquitin ligase HMG-CoA reductase degradation 1 (HRD1) prevents cell death in a cellular model of Parkinson's disease. Biochem Biophys Res Commun 506: 516-521 (2018)

*Tsuda M, Otani Y, Yonezawa A, Masui S, Ikemi Y, Denda M, Sato Y, Nakagawa S, Omura T, Imai S, Nakagawa T, Hayakari M, Matsubara K: Analysis of glycoforms and amino acids in infliximab and a biosimilar product using new method with LC/TOF-MS. Biol Pharm Bull 41: 1716-1721 (2018)

Isami K, *Imai S, Sukeishi A, Nagayasu K, Shirakawa H, *Nakagawa T, Kaneko S. The impact of mouse strain-specific spatial and temporal immune responses on the progression of neuropathic pain. Brain Behav Immun 74: 121-132 (2018).

Kamei J, Aizawa N, Nakagawa T, Kaneko S, Kume H, Homma Y, *Igawa Y: Attenuated lipopolysaccharideinduced inflammatory bladder hypersensitivity in mice deficient of transient receptor potential ankilin 1. Sci Rep 8: 15622 (2018)

Tsutsui M, Hirase R, Miyamura S, Nagayasu K, Nakagawa T, Mori Y, *Shirakawa H, Kaneko S. TRPM2 exacerbates central nervous system inflammation in experimental autoimmune encephalomyelitis by increasing production of CXCL2 chemokines. J Neurosci 38: 8484-8495 (2018)

*Omura T, Sasaoka M, Hashimoto G, Imai S, Yamamoto J, Sato Y, Nakagawa S, Yonezawa A, Nakagawa T, Yano I, Tasaki Y, Matsubara K. Oxicam-derived non-steroidal anti-inflammatory drugs suppress 1-methyl-4-phenyl pyridinium-induced cell death via repression of endoplasmic reticulum stress response and mitochondrial dysfunction in SH-SY5Y cells. Biochem Biophys Res Commun, 503: 2963-2969 (2018). doi: 10.1016/j.bbrc.2018.08.078.

Hiyama H, Yano Y, So K, Imai S, Nagayasu K, Shirakawa H, *Nakagawa T, Kaneko S: TRPA1 sensitization during diabetic vascular impairment contributes to cold hypersensitivity in a mouse model of painful diabetic peripheral neuropathy. Mol Pain 14: 1744806918789812 (2018). doi: 10.1177/1744806918789812

Kawai H, Asaoka N, Miyake T, Nagayasu K, Nakagawa T, *Shirakawa H, Kaneko S: Neurotropin inhibits neuronal activity through potentiation of sustained Kv currents in primary cultured DRG neurons. J Pharmacol Sci, 137: 313-316 (2018).

Kinoshita H, Nishitani N, Nagai Y, Andoh C, Asaoka N, Kawai H, Shibui N, *Nagayasu K, Shirakawa H, Nakagawa T, Kaneko S: Ketamine-induced prefrontal serotonin release is mediated by cholinergic neurons in the pedunculopontine tegmental nucleus. Int J Neuropsychopharmacol 21: 305-310 (2018). doi: 10.1093/ijnp/pyy007

深津祥央、池見泰明、米澤淳、山本浩貴、尾崎淳子、淺野理子、櫻井香織、上杉美和、吉田優子、傳田将也、大谷祐基、大村友博、今井哲司、中川俊作、中川貴之、今井博久、*松原和夫：医師からの指示として「残薬調整」をプレ印字した処方せんの医療経済効果. 日本病院薬剤師会雑誌 54: 307-312 (2018)

Miyanohara J, Kakae M, Nagayasu K, Nakagawa T, Mori Y, Arai K, *Shirakawa H, Kaneko S: TRPM2 channel aggravates CNS inflammation and cognitive impairment via activation of microglia in chronic cerebral hypoperfusion. J Neurosci 38: 3520-3533 (2018). DOI: https://doi.org/10.1523/JNEUROSCI.2451-17.2018

Hanai A, *Ishiguro H, Sozu T, Tsuda M, Yano I, Nakagawa T, Imai S, Hamabe Y, Toi M, Arai H, Tsuboyama T: Effects of cryotherapy on objective and subjective symptoms of paclitaxel-induced neuropathy: prospective self-controlled trial. J Nat Cancer Inst 110: 141-148 (2018). DOI: 10.1093/jnci/djx178

2017年

Sukeishi A, Isami K, Hiyama H, Imai S, Nagayasu K, Shirakawa H, *Nakagawa T, Kaneko S: Colchicine alleviates acute postoperative pain but delays wound repair in mice: roles of neutrophils and macrophages. Mol Pain 13: 1-12 (2017). DOI: 10.1177/1744806917743680

Oyama S, Dogishi K, Kodera M, Kakae M, Nagayasu K, Shirakawa H, *Nakagawa T, Kaneko S: Pathophysiological role of transient receptor potential ankyrin 1 in a mouse long-lasting cystitis model induced by an intravesical injection of hydrogen peroxide. Front Physiol 8: 877 (2017). DOI: 10.3389/fphys.2017.00877

Miyake T, Nakamura S, Zhao M, Hamano S, Inoue K, Numata T, Takahashi N, Nagayasu K, Shirakawa H, Mori Y, *Nakagawa T, Kaneko S: Distinct mechanism of cysteine oxidation-dependent activation and cold sensitization of human transient receptor potential ankyrin 1 channel by high and low oxaliplatin. Front Physiol 8: 878 (2017). DOI: 10.3389/fphys.2017.00878

Jin C, Yao Y, *Yonezawa A, Imai S, Yoshimatsu H, Otani Y, Omura T, Nakagawa S, Nakagawa T, Matsubara K: Riboflavin transporters RFVT/SLC52A mediate translocation of riboflavin, rather than FMN or FAD, across plasma membrane. Biol Pharm Bull 40: 1990-1995 (2017)

Asaoka N, Nishitani N, , Kinoshita H, Kawai H, Shibui N, Nagayasu K*, Shirakawa H, Nakagawa T, Kaneko S: Chronic antidepressant potentiates spontaneous activity of dorsal raphe serotonergic neurons by decreasing GABAB receptor-mediated inhibition of L-type calcium channels. Sci Rep 7: 13609 (2017)

Imai S, Koyanagi M, Azimi Z, Nakazato Y, Matsumoto M, Ogihara T, Yonezawa A, Omura T, Nakagawa S, Wakatsuki S, Araki T, Kaneko S, Nakagawa T*, Matsubara K: Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms. Sci Rep 7: 5947 (2017) doi: 10.1038/s41598-017-05784-1.

Shirakawa H*, Katsumoto R, Iida S, Miyake T, Higuchi T, Nagashima T, Nagayasu K, Nakagawa T, Kaneko S: Sphingosine-1-phosphate induces Ca²⁺ signaling and CXCL1 release via TRPC6 channel in astrocytes. Glia 65: 1005-1016 (2017)

Otani Y, Yonezawa A*, Tsuda M, Imai S, Ikemi Y, Nakagawa S, Omura T, Nakagawa T, Yano Y, Matsubara K: Time-dependent structural alteration of rituximab analyzed by LC/TOF-MS after a systemic administration to rats. PLoS ONE 12: e0169588 (2017)

Dogishi K, Okamoto K, Majima T, Konishi-Shiotsu S, Homan T, Kodera M, Oyama S, Oyama T, Shirakawa H, Yoshimura N, Nakagawa T*, Kaneko S: A rat long-lasting cystitis model induced by intravesical injection of hydrogen peroxide. Physiol Rep 5: e13127 (2017)

2016年

Miyake T, Nakamura S, Zhao M, So K, Inoue K, Numata T, Takahashi N, Shirakawa H, Mori Y, Nakagawa T*, Kaneko S: Cold sensitivity of TRPA1 is unveiled by the prolyl hydroxylation blockade-induced sensitization to ROS. Nat Commun 7: 12840 (2016)
（京都新聞9月16日25面、産経新聞9月21日23面、朝日新聞10月13日19面 他にて報道、京都大学HP「研究成果」に掲載）

Yoshimatsu H, Yonezawa A*, Yamanishi K, Yao Y, Sugano K, Nakagawa S, Imai S, Omura T, Nakagawa T, Yano I, Masuda S, Inui K, Matsubara K: Disruption of Slc52a3 gene causes neonatal lethality with riboflavin deficiency in mice. Sci Rep 6: 27557 (2016)

Nagashima T, Shirakawa H, Nakagawa T, Kaneko S*: Prevention of antipsychotic-induced hyperglycaemia by vitamin D: a data mining prediction followed by experimental exploration of the molecular mechanism. Sci Rep 6: 26375 (2016)
（京都新聞5月21日29面 他にて報道、京都大学HP「研究成果」に掲載）

So K, Tei Y, Zhao M, Miyake T, Hiyama H, Shirakawa H, Imai S, Mori Y, Nakagawa T*, Matsubara K, Kaneko S: Hypoxia-induced sensitization of TRPA1 in painful dysesthesia evoked by transient hindlimb ischemia/reperfusion in mice. Sci Rep 6: 23261 (2016)
（京都新聞3月18日25面、産経新聞3月18日夕刊 10面、毎日新聞3月26日30面に掲載、共同通信社、J-CASTニュース他に掲載、京都大学HP「研究成果」に掲載）

松村健吾、大谷祐基、大村友博、米澤淳、津田真弘、池見泰明、中川俊作、今井哲司、中川貴之、矢野育子、吉貴達寛、松原和夫*：LC/QTOF-MSによるフィルグラスチムバイオ後続品の定性?成分分析. 医療薬学 42: 613-619 (2016)

重面雄紀、小池眞菜美、萱野勇一郎、深津祥央、石塚良子、杉原玄一、今井哲司、矢野育子、中川貴之、村井俊哉、松原和夫*：薬剤師の介入による向精神薬適正使用と転倒?転落事故数への影響. 医療薬学 42: 174-184 (2016)

2015年

Dogishi K, Kodera M, Oyama S, Shirakawa H, Nakagawa T*, Kaneko S: Long-lasting pain-related behaviors in mouse chronic cystitis model induced by a single intravesical injection of hydrogen peroxide. J Pharmacol Sci 129: 244-246 (2015)

Miyanohara J, Shirakawa H*, Sanpei K, Nakagawa T, Kaneko S: A pathophysiological role of TRPV1 in ischemic injury after transient focal cerebral ischemia in mice. Biochem Biophys Res Commun 467: 478-483 (2015)

Koyama S, Omura T*, Yonezawa A, Imai S, Nakagawa S, Nakagawa T, Yano Y, Matsubara K: Gefitinib and erlotinib lead to phosphorylation of eukaryotic initiation factor 2α independent of epidermal growth factor receptor in A549 Cells. PLOS ONE 10: e0136176 (2015)

Imoto Y, Kira T, Sukeno M, Nishitani N, Nagayasu K, Nakagawa T, Kaneko S, Kobayashi K, Segi-Nishida E*: Role of the 5-HT₄ receptor in chronic fluoxetine treatment-induced neurogenic activity and granule cell dematuration in the dentate gyrus. Mol Brain 8: 29 (2015)

Miyake T, Shirakawa H*, Nakagawa T, Kaneko S: Activation of mitochondrial transient receptor potential vanilloid 1 channel contributes to microglial migration. Glia 63: 1870-1882 (2015)

Asaoka N, Nagayasu K, Nishitani N, Yamashiro M, Shirakawa H, Nakagawa T*, Kaneko S: Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus. Neuropharmacology 95: 261-268 (2015)

Asaoka N, Nagayasu K, Nishitani N, Yamashiro M, Shirakawa H, Nakagawa T*, Kaneko S: Inhibition of histone deacetylases enhances the function of serotoninergic neurons in organotypic raphe slice cultures. Neurosci Lett 593: 72-77 (2015)

So K, Haraguchi K, Asakura K, Isami K, Sakimoto S, Shirakawa H, Mori Y, Nakagawa T*, Kaneko S: Involvement of TRPM2 in a wide range of inflammatory and neuropathic pain mouse models. J Pharmacol Sci 127: 237-243 (2015)（第23回JPS優秀論文賞）

2014年

Nakagawa S*, Omura T, Yonezawa A, Yano I, Nakagawa T, Matsubara K: Extracellular nucleotides from dying cells act as molecular signals to promote wound repair in renal tubular injury. Am J Physiol Renal Physiol 307: F1404-F1411 (2014)

Kobori T, Fujiwara S, Miyagi K, Harada S, Nakamoto K, Nakagawa T, Takahashi H, Narita M, Tokuyama S*: Involvement of moesin in the development of morphine analgesic tolerance through P-glycoprotein at the blood–brain barrier. Drug Metab Pharmacokinet 29: 482-489 (2014)

Nishitani N, Nagayasu K, Asaoka N, Yamashiro M, Shirakawa H, Nakagawa T*, Kaneko S: Raphe AMPA receptors and nicotinic acetylcholine receptors mediate ketamine-induced serotonin release in the rat prefrontal cortex. Int J Neuropsychopharmacol 17: 1321-1326 (2014)

Zhao M, Nakamura S, Miyake T, So K, Shirakawa H, Tokuyama S, Narita M, Nakagawa T*, Kaneko S: Pharmacological characterization of standard analgesics on oxaliplatin-induced acute cold hypersensitivity in mice. J Pharmacol Sci 124: 514-517 (2014)

Miyake T, Shirakawa H, Kusano A, Sakimoto S, Konno M, Nakagawa T, Mori Y, Kaneko S*: TRPM2 contributes to LPS/IFNγ-induced production of nitric oxide via the p38/JNK pathway in microglia. Biochem Biophys Res Commun 444: 212-217 (2014)

Sakakiyama M, Maeda S, Isami K, Asakura K, So K, Shirakawa H, Nakagawa T*, Kaneko S: Preventive and alleviative effect of tramadol on neuropathic pain in rats: roles of α₂-adrenoceptors and spinal astrocytes. J Pharmacol Sci 124: 244-257 (2014)

2013年

Nagayasu K, Kitaichi M, Nishitani N, Asaoka N, Shirakawa H, Nakagawa T*, Kaneko S: Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release. Int J Neuropsychopharmacol 16: 2295-2306 (2013)

Isami K, Haraguchi K, So K, Maeda S, Asakura K, Shirakawa H, Mori Y, Nakagawa T*, Kaneko S: Involvement of TRPM2 in peripheral nerve injury-induced infiltration of peripheral immune cells into the spinal cord in mouse neuropathic pain model. PLOS ONE 8: e66410 (2013)

Munakata M, Shirakawa H, Nagayasu K, Miyanohara J, Miyake T, Nakagawa T, Katsuki H, Kaneko S*: The TRPC3 inhibitor Pyr3 improves outcomes and attenuates astrogliosis after intracerebral hemorrhage in mice. Stroke 44: 1981-1987 (2013)

Homan T, Tsuzuki T, Dogishi K, Shirakawa H, Oyama T, Nakagawa T, Kaneko S*: A novel mouse model of chronic inflammatory and overactive bladder by a single intravesical injection of hydrogen peroxide. J Pharmacol Sci 121: 327-337 (2013)

Sakai H, Sagara A, Matsumoto K, Hasegawa S, Sato K, Nishizaki M, Shoji T, Horie S, Nakagawa T, Tokuyama S, Narita M*: 5-Fluorouracil induces diarrhea with changes in the expression of inflammatory cytokines and aquaporins in mouse intestines. PLOS ONE 8: e54788 (2013)

2012年

Nakagawa T*, Nagayasu K, Nishitani N, Shirakawa H, Sekiguchi K, Ikarashi Y, Kase Y, Kaneko S: Yokukansan inhibits morphine tolerance and physical dependence in mice: the role of α_2a-adrenoceptor. Neuroscience 227: 336-349 (2012)

Zhao M, Isami K, Nakamura S, Shirakawa H, Nakagawa T*, Kaneko S: Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice. Mol Pain 8: 55 (2012)

Haraguchi K, Kawamoto A, Isami K, Maeda S, Kusano A, Asakura K, Shirakawa H, Mori Y, Nakagawa T*, Kaneko S: TRPM2 contributes to inflammatory and neuropathic pain through the aggravation of pronociceptive inflammatory responses in mice. J Neurosci 32: 3931-3941 (2012)

Konno M, Shirakawa H, Iida S, Sakimoto S, Matsutani I, Miyake T, Kageyama K, Nakagawa T, Shibasaki K, Kaneko S*: Stimulation of transient receptor potential vanilloid 4 channel suppresses abnormal activation of microglia induced by lipopolysaccharide. Glia 60: 761-770 (2012)

Konno M, Shirakawa H, Miyake T, Sakimoto S, Nakagawa T, Kaneko S*: Calumin, a Ca²⁺-binding protein on the endoplasmic reticulum, alters the ion permeability of Ca²⁺-activated Ca²⁺ release (CRAC) channels. Biochem Biophys Res Commun 417: 784-789 (2012)

2011年

Ibi M, Matsuno K, Matsumoto M, Sasaki M, Nakagawa T, Katsuyama M, Iwata K, Zhang J, Kaneko S, Yabe-Nishimura C*: Involvement of NOX1/NADPH oxidase in morphine-induced analgesia and tolerance. J Neurosci 31: 18094-18103 (2011)

Nakagawa T*, Suzuki Y, Nagayasu K, Kitaichi M, Shirakawa H, Kaneko S: Repeated exposure to methamphetamine, cocaine or morphine induces augmentation of dopamine release in rat mesocorticolimbic slice co-cultures. PLOS ONE 6(9): e24865 (2011)

2010年

Deyama S, Takishita A, Tanimoto S, Ide S, Nakagawa T, Satoh M, Minami M*: Roles of β- and α2-adrenoceptors within the central nucleus of the amygdala in the visceral pain-induced aversion in rats. J Pharmacol Sci 114: 123-126 (2010)

Shirakawa H, Sakimoto S, Nakao K, Sugishita A, Konno M, Iida S, Kusano A, Hashimoto E, Nakagawa T, Kaneko S*: TRPC3 Mediates thrombin-induced astrocyte activation and upregulates its own expression in rat cortical astrocytes. J Neurosci 30: 13116-13129 (2010)

Nagayasu K, Yatani Y, Kitaichi M, Kitagawa Y, Shirakawa H, Nakagawa T*, Kaneko S: Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective serotonin reuptake inhibitors on serotonin release. Br J Pharmacol 161: 1527-1541 (2010)

Nagayasu K, Kitaichi M, Shirakawa H, Nakagawa T*, Kaneko S: Sustained exposure to 3,4-methylenedioxymethamphetamine induces the augmentation of exocytotic serotonin release in rat organotypic raphe slice cultures. J Pharmacol Sci 113: 197-201 (2010)

2009年

Deyama S, Katayama T, Kondoh N, Nakagawa T, Kaneko S, Yamaguchi T, Yoshioka M, Minami M*: Role of enhanced noradrenergic transmission within the ventral bed nucleus of the stria terminalis in visceral pain-induced aversion in rats. Behav Brain Res 197: 279-283 (2009)

2008年

Maeda S, Kawamoto A, Yatani Y, Shirakawa H, Nakagawa T*, Kaneko S: Gene transfer of GLT-1, a glial glutamate transporter, into the spinal cord by recombinant adenovirus attenuates inflammatory and neuropathic pain in rats. Mol Pain 4: 65 (2008)

Shirakawa H, Yamaoka T, Sanpei K, Sasaoka H, Nakagawa T, Kaneko S*: TRPV1 stimulation triggers apoptotic cell death of rat cortical neurons. Biochem Biophys Res Commun 377: 1211-1215 (2008)

Nakagawa T*, Otsubo Y, Yatani Y, Shirakawa H, Kaneko S: Mechanisms of substrate transport-induced clustering of a glial glutamate transporter GLT-1 in astroglial-neuronal cultures. Eur J Neurosci 28: 1719-1730 (2008)

Ibi M, Matsuno K, Shiba D, Katsuyama M, Iwara K, Kakehi T, Nakagawa T, Sango K, Shirai Y, Yokoyama T, Kaneko S, Saito N, Yabe-Nishimura C*: Ractive oxygen species derived from NOX1/NADPH oxidase enhance inflammatory pain. J Neurosci 28: 9486-9494 (2008)

Deyama S, Katayama T, Nakagawa T, Kaneko S, Yamaguchi T, Yoshioka M, Minami M*: Activation of the β-adrenoceptor-protein kinase A signaling pathway within the ventral bed nucleus of the stria terminalis mediates the negative affective component of pain in rats. J Neurosci 28: 7728-7736 (2008)

Higuchi M, Suzuki Y, Yatani Y, Kitagawa Y, Nagayasu K, Shirakawa H, Nakagawa T*, Kaneko S: Augmentation of serotonin release by sustained exposure to 3,4-methylenedioxymethamphetamine and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons. J Neurochem 106: 2410-2420 (2008)

Nakagawa T*, Wakamatsu K, Maeda S, Shirakawa H, Kaneko S: Differential contribution of spinal mitogen-activated protein kinases to the phase of long-lasting allodynia evoked by intrathecal administration of ATP in rats. Biol Pharm Bull 31: 1164-1168 (2008)

Kume T, Kawato Y, Osakada F, Izumi Y, Katsuki H, Nakagawa T, Kaneko S, Niidome T, Takada-Takatori Y, Akaike A*: Dibutyryl cyclic AMP induces differentiation of human neuroblastoma SH-SY5Y cells into a noradrenergic phenotype. Neurosci Lett 443: 199-203 (2008)

Nakao K, Shirakawa H, Sugishita A, Matsutani I, Niidome T, Nakagawa T, Kaneko S*: Ca²⁺ mobilization mediated by transient receptor potential canonical 3 is associated with thrombin-induced morphological changes of 1321N1 human astrocytoma cells. J Neurosci Res 86: 2722-2732 (2008)

2007年

Yamauchi Y, Izumi T, Unemura K, Uenishi Y, Nakagawa T, Kaneko S*: Acceleration of serotonin transporter transport-associated current by 3,4-methylenedioxymethanphetamine (MDMA) under acidic conditions. Neurosci Lett 428: 72-76 (2007)

Tanaka K, Shirakawa H, Okada K, Konno M, Nakagawa T, Serikawa T, Kaneko S*: Increased Ca²⁺ channel currents in cerebellar Purkinje cells of the ataxic groggy rat. Neurosci Lett 426: 75-80 (2007)

Deyama S, Yamamoto J, Machida T, Tanimoto S, Nakagawa T, Kaneko S, Satoh M, Minami M*: Inhibition of glutamatergic transmission by morphine in the basolateral amygdaloid nucleus reduces pain-induced aversion. Neurosci Res 59: 199-204 (2007)

Nakagawa T*, Wakamatsu K, Zhang N, Maeda S, Minami M, Satoh M, Kaneko S: Intrathecal administration of ATP produces long-lasting allodynia in rats: differential mechanisms in the phase of the induction and maintenance. Neuroscience 147: 445-455 (2007)

Deyama S, Nakagawa T, Kaneko S, Uehara T, Minami M*: Involvement of the bed nucleus of the stria terminalis in the negative affective component of visceral and somatic pain in rats. Behav Brain Res 176: 367-371 (2007)

Shimamoto K*, Otsubo Y, Shigeri Y, Yasuda-Kamatani Y, Satoh M, Kaneko S, Nakagawa T: Characterization of the tritium-labeled analog of L-threo-β-benzyloxyaspartate binding to glutamate transporters. Mol Pharmacol 71: 294-302 (2007)

2006年

Fukui M, Nakagawa T*, Minami M, Satoh M, Kaneko S: Inhibitory role of supraspinal P2X₃/P2X_2/3 subtypes on nociception in rats. Mol Pain 2: 19 (2006)

2005年

Fujio M, Nakagawa T*, Suzuki Y, Satoh M, Kaneko S: Facilitative effect of a glutamate transporter inhibitor (2S,3S)-3-{3-[4-(trifluoromethyl)benzoylamino]benzyloxy}aspartate on the expression of methamphetamine-induced behavioral sensitization in rats. J Pharmacol Sci 99, 415-418 (2005)

Fujio M, Nakagawa T*, Sekiya Y, Ozawa T, Suzuki Y, Minami M, Satoh M, Kaneko S: Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats. Eur J Neurosci 22: 2744-2754 (2005)

Nakagawa T*, Yamamoto R, Fujio M, Suzuki Y, Minami M, Satoh M, Kaneko S: Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats. Neuroscience 134: 9-19 (2005)

Nakagawa T*, Fujio M, Ozawa T, Minami M, Satoh M: Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice. Behav Brain Res 156: 233-239 (2005)

2004年

Tanaka T, Minami M, Nakagawa T, Satoh M: Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci Res 48: 463-469 (2004)

Fukui M, Takishita A, Zhang N, Nakagawa T, Minami M, Satoh M: Involvement of locus coeruleus noradrenergic neurons in supraspinal antinociception by α,β-methylene-ATP in rats. J Pharmacol Sci 94: 153-160 (2004)

Sekiya Y, Nakagawa T, Ozawa T, Minami M, Satoh M: Facilitation of morphine withdrawal symptoms and morphine-induced conditioned place preference by a glutamate transporter inhibitor DL-threo-β-benzyloxyaspartate in rats. Eur J Pharmacol 485: 201-210 (2004)

Ozawa T, Nakagawa T, Sekiya Y, Minami M, Satoh, M: Effect of gene transfer of GLT-1, a glutamate transporter, into the locus coeruleus by recombinant adenoviruses on morphine physical dependence in rats. Eur J Neurosci 19: 221-226 (2004)

2003年

Tanimoto S, Nakagawa T, Yamauchi Y, Minami M, Satoh M: Differential contributions of the basolateral and central nuclei of the amygdala in the negative affective component of chemical somatic and visceral pains in rats. Eur J Neurosci 18: 2343-2350 (2003)

Nakagawa T, Katsuya A, Tanimoto S, Yamamoto J, Yamauchi Y, Minami M, Satoh M: Differential patterns of c-fos mRNA expression in the amygdaloid nuclei induced by chemical somatic and visceral noxious stimuli in rats. Neurosci Lett 344: 197-200 (2003)

Watanabe T, Nakagawa T, Yamamoto R, Maeda A, Minami M, Satoh M: Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Psychopharmacology 170: 80-88 (2003)

2002年

Watanabe T, Yamamoto R, Maeda A, Nakagawa T, Minami M, Satoh M: Effects of excitotoxic lesions of the central or basolateral nucleus of the amygdala on naloxone-precipitated withdrawal-induced conditioned place aversion in morphine-dependent rats. Brain Res 958: 423-428 (2002)

Okada M, Nakagawa T, Minami M, Satoh M: Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats. J Pharmacol Exp Ther 303: 66-73 (2002)

Yamakuni H, Kawaguchi N, Ohtani Y, Nakamura J, Katayama T, Nakagawa T, Minami M, Satoh M: ATP induces leukemia inhibitory factor mRNA in cultured rat astrocytes. J Neuroimmunol 129: 43-50 (2002)

Watanabe T, Nakagawa T, Yamamoto R, Maeda A, Minami M, Satoh M: Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn J Pharmacol 88: 399-406 (2002)

Yoshida K, Nakagawa T, Kaneko S, Akaike A, Satoh M: Adenosine 5'-triphosphate inhibits slow depolarization induced by repetitive dorsal root stimulation in substantia gelatinosa neurons of the adult rat spinal cord slices via P2Y purinoceptors. Neurosci Lett 320: 121-124 (2002)

2001年

Nakagawa T, Minami M, Satoh M: Up-regulation of RGS4 mRNA by opioid agonists in PC12 cells expressing cloned μ- or κ-opioid receptors. Eur J Pharmacol 433: 29-36 (2001)

Fukui M, Nakagawa T, Minami M, Satoh M: Involvement of β2-adrenergic and μ-opioid receptors in antinociception produced by intracerebroventricular administration of α,β-methylene-ATP. Jpn J Pharmacol 86: 423-428 (2001)

Ozawa T, Nakagawa T, Shige K, Minami M, Satoh M: Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal. Brain Res 905: 254-258 (2001)

Nakagawa T, Ozawa T, Shige K, Yamamoto R, Minami M, Satoh M: Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator. Eur J Pharmacol 419: 39-45 (2001)

Fukui M, Nakagawa T, Minami M, Satoh M: Antinociceptive effects of intracerebroventricularly administered P2 purinoceptor agonists in the rat. Eur J Pharmacol 419: 25-31 (2001)

2000年

Nakagawa T, Masuda T, Watanabe T, Minami M, Satoh M: Possible involvement of the locus coeruleus in inhibition by prostanoid EP₃ receptor-selective agonists of morphine withdrawal syndrome in rats. Eur J Pharmacol 390: 257-266 (2000)

1999年

Nakagawa T, Ozawa T, Minami M, Satoh M: Sensitization of the adenylyl cyclase system in cloned κ-opioid receptor-transfected cells following sustained agonist treatment: a chimeric study using G protein α_i2/α_q subunits. Jpn J Pharmacol 81: 353-361 (1999)

Nakagawa T, Kaneko M, Inamura S, Satoh M: Intracerebroventricular administration of nocistatin reduces inflammatory hyperalgesia in rats. Neurosci Lett 265: 64-66 (1999)

Ozawa T, Nakagawa T, Minami M, Satoh M: Supersensitization of the adenylyl cyclase system in Chinese hamster ovary cells co-expressing cloned opioid receptors and Gz, a PTX-insensitive G protein. Neurosci Lett 267: 117-120 (1999)

1998年

Seki T, Minami M, Kimura C, Uehara T, Nakagawa T, Satoh M: Bremazocine recognizes the difference in four amino acid residues to discriminate between a nociceptin receptor and opioid receptors. Jpn J Pharmacol 77: 301-306 (1998)

Seki T, Minami M, Nakagawa T, Ienaga Y, Morisada A, Satoh M: DAMGO recognizes four residues in the third extracellular loop to discriminate between μ- and κ-opioid receptors. Eur J Pharmacol 350: 301-310 (1998)

1996年

Katsumata S, Ienaga Y, Minami M, Nakagawa T, Kanematsu K, Satoh M: Pharmacological characterization of KT-90 using cloned μ-, δ- and κ-opioid receptors. Eur J Pharmacol 312: 349-355 (1996)

Minami M, Nakagawa T, Seki T, Onogi T, Aoki Y, Katao Y, Katsumata S, Satoh M: A single residue, Lys¹⁰⁸, of the δ-opioid receptor prevents the μ-opioid-selective ligand [D-Ala², N-MePhe⁴, Gly-ol⁵]enkephalin from binding to the δ-opioid receptor. Mol Pharmacol 50: 1413-1422 (1996)

1995年

Katsumata S, Minami M, Nakagawa T, Iwamura T, Satoh M: Pharmacological study of dihydroetorphine in cloned μ-, δ- and κ-opioid receptors. Eur J Pharmacol 291: 367-373 (1995)

Nakagawa T, Minami M, Kastumata S, Ienaga Y, Satoh M: Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP₃ receptor. Br J Pharmacol 116: 2661-2666 (1995)

Minami M, Onogi T, Nakagawa T, Katao Y, Aoki Y, Katsumata S, Satoh M: DAMGO, a m-opioid receptor selective ligand, distinguishes between μ- and κ-opioid receptors at a different region from that for the distinction between μ- and δ-opioid receptors. FEBS Lett 364: 23-27 (1995)

Onogi T, Minami M, Katao Y, Nakagawa T, Aoki Y, Toya T, Katsumata S, Satoh M: DAMGO, a -μopioid receptor selective agonist, distinguishes between μ- and δ-opioid receptors around their first extracellular loops. FEBS Lett 357: 93-97 (1995)

Katsumata S, Minami M, Nakagawa T, Satoh M: Intracisternal administration of interleukin-1β attenuates naloxone-precipitated withdrawal in morphine-dependent mice. Eur J Pharmacol 278: 143-150 (1995)